The World's First Catheter with Integrated Distal Tip Vibration
Deep Vein Thrombosis (DVT)
Clot formed in the deep vein, typically in the leg
Venous Thromboembolism
900k
>50%
15%
5%
Cases in the US
DVT Patients will be diagnosed with a PE
Mortality in Hospitalized PE Patients
Occurrence of PE "Lollipopping"
or "Corking"
Pulmonary Embolism (PE)
Clot migrating from the legs obstruct the pulmonary artery to the lung
First-Gen Solutions
Limitations:
Design Targets:
-
Prolonged hospital stay in ICU
-
​Introduces significant bleeding risks
-
Marginally effective
-
Slow improvement of pulmonary perfusion
-
Not applicable treatment method for high-risk patients that require urgent treatment
-
Focused on usage of thrombolytics to break up present clots
- Catheter-Directed Thrombolysis for focused and consistent infusion of thrombolytic into the clot region
-
Ultrasound-Assisted Thrombolysis for increased delivery of thrombolytics to the clot
-
Improve blood flow and prevent damage to surrounding tissues
Limitations:
Second-Gen Solutions
-
Demonstrate the clinical efficacy of aspiration thrombectomy
-
Navigate through tortuous anatomy to reach and retrieve the clot
-
Withstand suction forces without collapsing
-
Reduce rate of corking/occlusion
-
Reduce hospital stay
-
Thrombus can "cork" the catheter tip allowing for potential embolization
-
Vessels can collapse around the catheter during suction preventing clot ingestion
-
Using “stronger suction” can result in clinically significant blood loss
-
Large bore catheters impart larger forces during navigation and delivery, increasing potential for vascular injury
Design Targets:
Next-Gen: Our Solution
Vibrating
Distal Tip
No Capital Equipment
May Reduce Procedural Blood Loss
Low Profile
Improved Trackability
May Improve Clot Removal Efficiency
Pre-Clinical Testing, June 2023
Clinical Advisors
Dr. Jan Engström
Interventional Radiologist
Karolinska University Hospital
Dr. Asma Khaliq
Interventional Cardiologist​
​Montefiore Medical Center
Dr. John Moriarty
Interventional Radiologist
David Geffen School of Medicine at UCLA
Dr. David Holmes
Interventional Cardiologist
Mayo Clinic
Dr. Chris Manion
Interventional Cardiologist
Gates Vascular Institute
Dr. David Zlotnick
Interventional Cardiologist
Gates Vascular Institute
Strategic Partners
Get to Know Us
Headquartered in Buffalo, New York, Vicora is the first portfolio company of Egret Healthcare Ventures. Founded to help create a sustainable start up ecosystem that fosters medical device innovation, Egret Healthcare Ventures includes a seasoned group of partners across finance, healthcare, innovation, product development and the regulatory world. They have a strong track record of successful startup business creation, advancement and exits. Working collaboratively with regional strengths and centers of excellence, Egret Healthcare Ventures is building a disruptive portfolio of innovative companies driven by clinical and technological advancement.
Latest News
Two Medical Device Startups Launch in Buffalo with Seed Funding
October 12, 2022 | Press Release
Two Local Medical Device Startups on the Road to Commercialization
December 8, 2023 | News Article
UB CAT Funds Ten Life Sciences Research Projects
December 11, 2023 | News Article
UB CAT Announces R&D Collaboration Awards to Eight Life Sciences Companies
September 25, 2024 | News Article
UB CAT Supports Nine Faculty-Industry Life Sciences R&D Projects
September 27, 2024 | News Article
CONTACT US
701 Ellicott Street
Buffalo, NY 14203
​​